Brello vs Fridays: Compounded GLP-1 Models Compared

From the PlexusDx Education Hub, this comparison continues our coverage of compounded GLP-1 telehealth, pricing transparency, and metabolic genetics. See all Peptides & GLP-1 education.

An independent editorial comparison. PlexusDx is not affiliated with Brello or Fridays and receives no compensation or affiliate revenue from either brand.

Full head-to-head: PlexusDx vs Fridays →

Brello and Fridays are both telehealth programs paired with compounding pharmacies, which makes them easy to confuse and worth separating carefully. This comparison focuses on the compounded model itself, on how visible each program's pricing is, on what "included" actually means, and on the inherited biology that neither program evaluates. As of April 2026.

Two compounded-pharmacy telehealth models

Brello and Fridays share a structural DNA: both are telehealth programs built around compounding pharmacies. Brello Health and Fridays Health each deliver care virtually, issue prescriptions when appropriate, and lean on 503A-compounded semaglutide and tirzepatide alongside any brand options. The similarity is real, which makes the differences in pricing visibility and included support the useful place to look.

Brello: telehealth with a compounding pathway

Brello operates as telehealth plus compounded pharmacy, typically including virtual clinical evaluation, provider-issued prescriptions, and compounded or brand GLP-1 dispensing via licensed pathways. Because program URLs and details change, confirm Brello's current structure on the brand's own website at the time you read this rather than relying on a cached description.

Fridays: published rates and included support

Fridays makes its pricing unusually visible. As of its own pricing page (joinfridays.com/pricing, verified 2026-07-20), it advertises compounded semaglutide at $249/mo and compounded tirzepatide at $359/mo month-to-month, with $0 membership, free shipping, and included coaching and dietitian support; prepaid multi-month bundles lower the per-month equivalent to roughly $150/mo semaglutide and $240/mo tirzepatide on a paid-annually plan. Verify current terms on Fridays's official website.

The shared compound science

Both programs rest on the same molecules. GLP-1 receptor agonists and the dual agonist tirzepatide act on appetite, satiety, and gastric emptying, with evidence from STEP (NEJM 2021), SURMOUNT (NEJM 2022), and SURMOUNT-OSA (NEJM 2024). The dispensing brand does not alter the pharmacology; the compound does the work regardless of which program routes it.

Comparing what is bundled and what is billed

With compounded programs, the honest comparison is not a single sticker price but what a monthly figure includes — medication, provider access, coaching, shipping, and membership. Fridays discloses those inclusions on its page; for Brello, read the current terms directly. Because compounded-program pricing can move quickly, treat any figure as a snapshot and confirm before enrolling.

The genetic variable no subscription reads

Here is the layer none of these telehealth workflows examine: the inherited biology that sets the stage before any GLP-1 molecule arrives. Markers in FTO, MC4R, and TCF7L2 describe the inherited metabolic profile sitting beneath any compounded GLP-1, no matter which pharmacy fills it. These are pathway-level markers. They do not predict how you will respond to any particular drug, but they describe the metabolic terrain a prescriber is writing into. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across that terrain, mapping appetite regulation, satiety, and energy-balance biology so a conversation with your own clinician starts from data rather than guesswork. It is not a pharmacogenomic test and never forecasts a medication's effect.

PlexusDx delivers semaglutide and tirzepatide via its Weight Management Protocols — Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Its month-to-month rates run roughly $60–$70/mo below Fridays' advertised month-to-month for both compounds, while Fridays' prepaid bundles undercut PlexusDx per month — with genetic context added on top.

Not affiliated: PlexusDx has no affiliation and no commercial relationship with Brello or the other programs discussed in this review.

Related reading on PlexusDx: GLP 1 Hormone, What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist.

This is educational content. PlexusDx is unaffiliated with Brello or Fridays and has no commercial relationship with either. PlexusDx offers semaglutide and tirzepatide via its own Weight Management Protocols; this comparison reviews compounded telehealth approaches. The Precision Peptide Genetic Test reads gene–pathway influence, not medication response. Consult a qualified clinician before any peptide protocol.

Add a genetics-first option to the comparison: view the PlexusDx Weight Management Protocols, or order the Precision Peptide Genetic Test to map your biology before choosing.

Frequently Asked Questions

Are Brello and Fridays the same kind of program?

They are similar in structure — both are telehealth services paired with compounding pharmacies that can dispense compounded semaglutide and tirzepatide. They differ in pricing visibility and included support. Fridays publishes detailed rates; for Brello, confirm current terms on its own site, since program details and URLs change over time.

How does Fridays pricing compare with PlexusDx?

PlexusDx's month-to-month rates run roughly $60–$70/mo below Fridays' advertised month-to-month for both compounds, while Fridays' prepaid 3- and 6-month bundles undercut PlexusDx per month. The better value depends on whether you buy month-to-month or prepay, so match the comparison to your intended payment plan.

What should you check before choosing a compounded program?

Look past the headline number to what is bundled — medication, provider access, coaching, shipping, and membership — plus the pharmacy pathway and oversight. Compounded 503A preparations are not FDA-approved brand products. Confirm current, itemized terms on each brand's own site, since compounded-program pricing can move quickly.

Does a genetic test change which program to pick?

It informs the decision rather than dictating it. The Precision Peptide Genetic Test maps pathway-level variants in FTO, MC4R, and TCF7L2 that describe your baseline metabolism. It does not predict response to any compound or program, but it gives you context to weigh alongside price and structure.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.